- Home
- FEDU vs OCEA Comparison
FEDU vs OCEA Comparison
Compare FEDU & OCEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEDU
- OCEA
- Stock Information
- Founded
- FEDU 2007
- OCEA 2019
- Country
- FEDU China
- OCEA United States
- Employees
- FEDU N/A
- OCEA N/A
- Industry
- FEDU
- OCEA Biotechnology: Pharmaceutical Preparations
- Sector
- FEDU
- OCEA Health Care
- Exchange
- FEDU NYSE
- OCEA Nasdaq
- Market Cap
- FEDU 22.2M
- OCEA 20.5M
- IPO Year
- FEDU 2017
- OCEA N/A
- Fundamental
- Price
- FEDU $10.17
- OCEA $0.13
- Analyst Decision
- FEDU
- OCEA
- Analyst Count
- FEDU 0
- OCEA 0
- Target Price
- FEDU N/A
- OCEA N/A
- AVG Volume (30 Days)
- FEDU 3.3K
- OCEA 88.9M
- Earning Date
- FEDU 12-20-2024
- OCEA 01-13-2025
- Dividend Yield
- FEDU 22.42%
- OCEA N/A
- EPS Growth
- FEDU N/A
- OCEA N/A
- EPS
- FEDU 0.12
- OCEA N/A
- Revenue
- FEDU $27,971,139.00
- OCEA N/A
- Revenue This Year
- FEDU N/A
- OCEA N/A
- Revenue Next Year
- FEDU N/A
- OCEA N/A
- P/E Ratio
- FEDU $85.33
- OCEA N/A
- Revenue Growth
- FEDU 141.14
- OCEA N/A
- 52 Week Low
- FEDU $7.41
- OCEA $0.11
- 52 Week High
- FEDU $22.70
- OCEA $7.79
- Technical
- Relative Strength Index (RSI)
- FEDU 48.25
- OCEA 28.02
- Support Level
- FEDU $9.78
- OCEA $0.12
- Resistance Level
- FEDU $10.77
- OCEA $0.16
- Average True Range (ATR)
- FEDU 0.53
- OCEA 0.04
- MACD
- FEDU 0.04
- OCEA 0.01
- Stochastic Oscillator
- FEDU 49.43
- OCEA 8.66
About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)
Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.